• OPEN AN ACCOUNT
Indian Indices
Nifty
26,052.65 142.60
(0.55%)
Sensex
85,186.47 513.45
( 0.61%)
Bank Nifty
59,216.05 316.80
( 0.54%)
Nifty IT
37,044.65 1,069.45
( 2.97%)
Global Indices
Nasdaq
46,120.46 -490.79
(-1.05%)
Dow Jones
6,640.03 -53.38
(-0.80%)
Hang Seng
48,614.36 -88.62
(-0.18%)
Nikkei 225
9,542.07 -10.23
(-0.11%)
Forex
USD-INR
88.63 -0.03
(-0.03%)
EUR-INR
102.78 -0.24
(-0.23%)
GBP-INR
116.64 -0.09
(-0.08%)
JPY-INR
0.57 0.00
(-0.26%)

EQUITY - MARKET SCREENER

Thyrocare Technologies Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539871
INE594H01019
97.3545632
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
THYROCARE
70.29
8443.26
EPS(TTM)
Face Value()
Div & Yield %
22.64
10
1.32
 

thyrocare technologies ltd
Thyrocare Technologies promoter offloads shares
Oct 24,2025
Docon Technologies Private Limited (“Docon”), Promoter of Thyrocare Technologies has sold 53,32,860 equity shares of the Company through market trades on 24th October 2025 for an aggregate gross consideration of Rs. 667.69 crore (rounded off), at an average price of approximately Rs. 1,252.03 per share (rounded off).

The number of shares sold constitutes approximately 10% of the total paid-up capital of the Company. Following this transaction, Docon continues to be a promoter of the Company. Post this transaction, the promoter shareholding in the Company stands reduced to 60.93% from the pre-transaction shareholding of 70.98%.